KPIs & Operating Metrics(New)
Breakdown Of AssetsCommercial Revenue BreakdownCost Of SalesEmployee StatisticsGross Margin %Gross ProfitOperating Expense SegregationOpex As A % Of RevenueProfitabilityProfitability %Profitability AnnualProfitability Annual %Property, Plant And Equipment BreakdownRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By Contracts With CustomerRevenue By Contracts With Customer %Revenue By Timing Of RecognitionRevenue By Timing Of Recognition %Total Revenue Breakdown
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Gross Profit: 2017-2024

Historic Gross Profit for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to $2.4 billion.

  • BioNTech SE's Gross Profit rose 36.88% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 5.16%. This contributed to the annual value of $2.4 billion for FY2024, which is 31.82% down from last year.
  • According to the latest figures from FY2024, BioNTech SE's Gross Profit is $2.4 billion, which was down 31.82% from $3.5 billion recorded in FY2023.
  • In the past 5 years, BioNTech SE's Gross Profit registered a high of $18.4 billion during FY2021, and its lowest value of $504.3 million during FY2020.
  • For the 3-year period, BioNTech SE's Gross Profit averaged around $6.8 billion, with its median value being $3.5 billion (2023).
  • In the last 5 years, BioNTech SE's Gross Profit surged by 3,544.01% in 2021 and then tumbled by 76.29% in 2023.
  • BioNTech SE's Gross Profit (Yearly) stood at $504.3 million in 2020, then spiked by 3,544.01% to $18.4 billion in 2021, then dropped by 20.53% to $14.6 billion in 2022, then crashed by 76.29% to $3.5 billion in 2023, then tumbled by 31.82% to $2.4 billion in 2024.